Provided by Tiger Trade Technology Pte. Ltd.

Immunic, Inc.

16.71
+0.20501.24%
Volume:76.67K
Turnover:1.27M
Market Cap:227.19M
PE:-4.18
High:16.83
Open:16.48
Low:16.06
Close:16.50
52wk High:17.43
52wk Low:5.06
Shares:13.60M
Float Shares:11.92M
Volume Ratio:0.53
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9979
EPS(LYR):-6.2414
ROE:-138.17%
ROA:-66.80%
PB:1.78
PE(LYR):-2.68

Loading ...

Press Release: Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton

Dow Jones
·
Mar 31

Guggenheim Initiates Coverage on Immunic With Buy Rating, $7 Price Target

MT Newswires Live
·
Mar 24

Immunic Initiated at Buy by Guggenheim

Dow Jones
·
Mar 24

Immunic initiated with a Buy at Guggenheim

TIPRANKS
·
Mar 24

Should Extended European Patent Protection for Vidofludimus Calcium Reshape Immunic’s (IMUX) Long-Term Value Proposition?

Simply Wall St.
·
Mar 14

Eqs-News: Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium

THOMSON REUTERS
·
Mar 10

Immunic to Join Leerink Partners Global Healthcare Conference and Stifel 2026 Virtual CNS Forum

Reuters
·
Mar 03

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Intellia Therapeutics (NTLA) and Immunic (IMUX)

TIPRANKS
·
Mar 02

Immunic Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 02

Immunic, Inc. : H.c. Wainwright Cuts Target Price to $5 From $8

THOMSON REUTERS
·
Mar 02

Immunic Inc. Files Initial Beneficial Ownership Statement for Director Robert Thorvald Nagel

Reuters
·
Feb 28

Immunic Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 26

Immunic Q4 EPS $(0.04) Beats $(0.09) Estimate

Benzinga Earnings
·
Feb 26

IMUX FY 2025 Other Income (Expense) Swings to USD 5.0 million from (USD 1.0 million)

Reuters
·
Feb 26

Immunic Inc - Simona Skerjanec Named Interim Chairperson of Board

THOMSON REUTERS
·
Feb 26

Immunic Inc - Raises $200 Mln in Private Placement

THOMSON REUTERS
·
Feb 26

Press Release: Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Feb 26